Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Cleola Anderiesz"'
Autor:
Vivienne Milch, Anne E. Nelson, Melissa Austen, Debra Hector, Scott Turnbull, Rahul Sathiaraj, Carolyn Der Vartanian, Rhona Wang, Cleola Anderiesz, Dorothy Keefe
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEWith successive infection waves and the spread of more infectious variants, the COVID-19 pandemic continues to have major impacts on health care. To achieve best outcomes for patients with cancer during a pandemic, efforts to minimize the incr
Externí odkaz:
https://doaj.org/article/acb3211a678747a7955cf119a1269831
Autor:
Isabelle Schaefer, Nicole Heneka, Tim Luckett, Meera R. Agar, Suzanne K. Chambers, David C. Currow, Georgia Halkett, Domenica Disalvo, Ingrid Amgarth-Duff, Cleola Anderiesz, Jane L. Phillips
Publikováno v:
BMC Palliative Care, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Background A primary brain cancer diagnosis is a distressing, life changing event. It adversely affects the quality of life for the person living with brain cancer and their families (‘carers’). Timely access to evidence-based informatio
Externí odkaz:
https://doaj.org/article/59688f563be74deab32d44779ace94d3
Autor:
Debra Hector, Vivienne Milch, Carolyn Der Vartanian, M. Austen, Cleola Anderiesz, Dorothy M. K. Keefe, R. Wang
Publikováno v:
The Medical Journal of Australia
Introduction Driven by the need to reduce risk of SARS‐CoV‐2 infection and optimise use of health system resources, while maximising patient outcomes, the COVID‐19 pandemic has prompted unprecedented changes in cancer care. Some new or modified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca63f4f14959e1645c724b5b763fa0d
https://pubmed.ncbi.nlm.nih.gov/34689343
https://pubmed.ncbi.nlm.nih.gov/34689343
Autor:
Megan Varlow, Sanchia Aranda, David Roder, David C. Currow, Dorothy M. K. Keefe, Cleola Anderiesz, Vivienne Milch, Karen Canfell
Publikováno v:
The Medical journal of Australia. 214(10)
There are an increasing number of publications estimating the extent of cancer overdiagnosis, which for breast cancer is in the context of population cancer screening programs. Researchers investigating overdiagnosis point to a range of related harms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0425cfd1451770e2fc9ddf355d4f0e6a
https://pubmed.ncbi.nlm.nih.gov/33993477
https://pubmed.ncbi.nlm.nih.gov/33993477
Autor:
Tim Luckett, Isabelle Schaefer, Domenica Disalvo, David C. Currow, Georgia Halkett, Nicole Heneka, Meera Agar, Ingrid Amgarth-Duff, Cleola Anderiesz, Jane Phillips, Suzanne K. Chambers
Publikováno v:
BMC Palliative Care
BMC Palliative Care, Vol 20, Iss 1, Pp 1-11 (2021)
BMC Palliative Care, Vol 20, Iss 1, Pp 1-11 (2021)
Background A primary brain cancer diagnosis is a distressing, life changing event. It adversely affects the quality of life for the person living with brain cancer and their families (‘carers’). Timely access to evidence-based information is crit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f6e1e1066343c82ae796cf776b97b6
https://pubmed.ncbi.nlm.nih.gov/33485331
https://pubmed.ncbi.nlm.nih.gov/33485331
Autor:
Jane M. Young, Gemma Collett, Nicole Rankin, David J. Barnes, Ivana Durcinoska, Cleola Anderiesz, Prunella Blinman
Publikováno v:
Supportive Care in Cancer. 27:485-493
PURPOSE: Improving the coordination of care for people with lung cancer is a health priority. This study aimed to tailor an existing care coordination survey for a lung cancer population, investigate coordination experiences for patients who had rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d56b42eaec3577f1830e71692abbbe
https://doi.org/10.1007/s00520-018-4338-3
https://doi.org/10.1007/s00520-018-4338-3
Autor:
M. Austen, Dorothy M. K. Keefe, L. Liu, C. Der Vartanian, Stephen P. Ackland, R. Wang, Vivienne Milch, Cleola Anderiesz, C. B. Woods
Publikováno v:
Journal of Clinical Oncology. 39:e18685-e18685
e18685 Background: Health systems pressures during the COVID-19 pandemic have driven adoption of innovative models of cancer care which optimise resources and protect patients and staff. High-value changes should be identified and retained to improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00cfb5bbffe2bf34f48b25cdca1993ef
https://doi.org/10.1200/jco.2021.39.15_suppl.e18685
https://doi.org/10.1200/jco.2021.39.15_suppl.e18685
Autor:
G. Garvey, D. Mary, M. Austen, C. Der Vartanian, R. Wang, C. B. Woods, K. Keefe, Vivienne Milch, Cleola Anderiesz, J. Salisbury
Publikováno v:
Journal of Clinical Oncology. 39:e24028-e24028
e24028 Background: Given the impact of COVID-19 on Indigenous and ethnic minority populations observed globally, keeping COVID-19 out of vulnerable Aboriginal and Torres Strait Islander (Indigenous Australian) communities remains a priority. Compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::991a1c5a2812ca060613166592ea3673
https://doi.org/10.1200/jco.2021.39.15_suppl.e24028
https://doi.org/10.1200/jco.2021.39.15_suppl.e24028
Autor:
Carolyn Der Vartanian, Dorothy M. K. Keefe, M. Austen, Debra Hector, Cleola Anderiesz, Vivienne Milch, Scott Turnbull, R. Wang
Publikováno v:
Journal of Clinical Oncology. 39:e18628-e18628
e18628 Background: At the start of the COVID-19 pandemic, a plan for cancer management during a pandemic did not exist. It soon became clear that without proper planning, cancer outcomes would worsen. Cancer patients are at increased risk of COVID-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55a8d39751d480d3202a139be725d596
https://doi.org/10.1200/jco.2021.39.15_suppl.e18628
https://doi.org/10.1200/jco.2021.39.15_suppl.e18628
Autor:
Dorothy M. K. Keefe, David Roder, Vivienne Milch, Christine Biondi, Cleola Anderiesz, Van Nguyen, Kristie Cooper, Alan Woods, Regina Ryan, R. Wang
Publikováno v:
Journal of Clinical Oncology. 39:e18812-e18812
e18812 Background: Australian oncologists reported dramatic decreases in cancer referrals during the pandemic. As real time data were difficult to acquire, Cancer Australia used surrogate measures to infer where reductions in medical services occurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc331b885013a03beb0b621352c10ede
https://doi.org/10.1200/jco.2021.39.15_suppl.e18812
https://doi.org/10.1200/jco.2021.39.15_suppl.e18812